2025 India Blood Group Typing Market Revenue Opportunities Report
Description
The 2025 India Blood Group Typing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Group Typing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively operating in the Blood Group Typing Market in India include Danaher Corp., Bio-Rad Laboratories Inc., Grifols S.A., and Merck KGaA. Danaher, through its Beckman Coulter division, along with Bio-Rad Laboratories and Grifols, are leading market players providing advanced blood typing instruments, reagents, and integrated diagnostic solutions. Bio-Rad leverages digital PCR technology and has recently expanded capabilities to improve precision in transfusion medicine. Grifols, known for its broad serology menus and automated systems, also targets the mid-volume hospital segment in India. Merck KGaA contributes specialized reagents and consumables crucial for testing accuracy.
These companies benefit from India's rapidly growing market, with a projected CAGR of 13.7%, and total revenue expected to reach approximately USD 275 million by 2030. The growth is driven by increasing demand for blood transfusions, enhanced automation, and molecular techniques such as PCR and NGS being adopted in Indian healthcare. In addition, these multinational firms face competition from regional players and focus on collaborations, reagent service contracts, and expanding mid-tier healthcare penetration. Their offerings often include integrated solutions covering peri-operative hematology and coagulation testing, addressing India's diverse and expanding clinical needs.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Group Typing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively operating in the Blood Group Typing Market in India include Danaher Corp., Bio-Rad Laboratories Inc., Grifols S.A., and Merck KGaA. Danaher, through its Beckman Coulter division, along with Bio-Rad Laboratories and Grifols, are leading market players providing advanced blood typing instruments, reagents, and integrated diagnostic solutions. Bio-Rad leverages digital PCR technology and has recently expanded capabilities to improve precision in transfusion medicine. Grifols, known for its broad serology menus and automated systems, also targets the mid-volume hospital segment in India. Merck KGaA contributes specialized reagents and consumables crucial for testing accuracy.
These companies benefit from India's rapidly growing market, with a projected CAGR of 13.7%, and total revenue expected to reach approximately USD 275 million by 2030. The growth is driven by increasing demand for blood transfusions, enhanced automation, and molecular techniques such as PCR and NGS being adopted in Indian healthcare. In addition, these multinational firms face competition from regional players and focus on collaborations, reagent service contracts, and expanding mid-tier healthcare penetration. Their offerings often include integrated solutions covering peri-operative hematology and coagulation testing, addressing India's diverse and expanding clinical needs.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
